Health products available at Walmart, Bed Bath & Beyond, CVS and CURE Pharmaceutical, Inc (Ticker Symbol: CURR)


CURR and Sera Labs

CURR nicole-kidman

NEWS products

CURR Will Be Topical

Movie NEWS

Marketing partnerships for advanced health and beauty lines; Products available at Walmart: CURE Pharmaceutical (Ticker: CURR)

Checkmate Pharmaceuticals, Inc. (OTCMKTS: CURR)

This is another fantastic achievement in branding and expansion. Our goal is to differentiate our products using advanced and proprietary technologies, including unique high-tech delivery systems”

— CEO and Strategic Director of CURR

OXNARD, CALIFORNIA, USA, May 10, 2022 / — Marketing partnerships for Advanced Health and beauty Lines; Products available at Walmart, Bed Bath & Beyond, CVS and CURE Pharmaceutical (Ticker: CURR)

 Patented techniques improve efficiency, safety and patient experience.

 25,000 square feet, FDA, NSF registered® and a cGMP certified manufacturing facility.

 Skincare line sold at select Walmart, CVS, and Bed Bath & Beyond Stores.

 Oral Thin Film Strip, Nutri-Strips™ on the shelves of CVS and

 Collaboration with Milagro Pharmaceuticals for the registration and approval for sale of the oral thin film Sildenafil for the treatment of erectile dysfunction in Mexico.

 Exclusive distribution agreement with Northern Response International.

 Patent approval on CUREfilm Blue™ technology for the treatment of erectile dysfunction.

CURE Pharmaceutical (OTCQB: CURR) is a fully integrated and progressive drug delivery company. The CURR team has extensive experience in formulating and manufacturing over-the-counter products, pharmaceuticals and veterinary drugs, placing quality and service at the top of its priorities, earning the trust and respect of customers worldwide. whole world.

CURR is the pioneer developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate-release and controlled-release drug delivery technologies designed to improve efficacy, safety and experience. patients for a wide range of active ingredients. CURR delivery technologies include CUREfilm®, an advanced oral thin film; and CUREdrops™, an emulsion technology that can be incorporated into different dosage forms (film, tincture, beverages, etc.), among others. CURR’s proprietary clinical pipeline includes CUREfilm®Blue (sildenafil to treat erectile dysfunction) and CUREfilm®Canna (THC and CBD).

As a vertically integrated company, CURR operates a 25,000 square foot, FDA, NSF registered® and a cGMP-certified manufacturing facility allowing it to partner with pharmaceutical and wellness companies around the world for private and white-label production. CURR currently has partnerships in the United States, China, Mexico, Canada, Israel and other markets in Europe.

 CURR subsidiary Sera Labs Inc. products are now available at Walmart, Bed Bath & Beyond, CVS and

On April 14, CURR’s wholly-owned subsidiary Sera Labs announced that its Seratopical Revolution skincare line would be sold at select Walmart stores, as well as CVS and Bed Bath & Beyond stores. CURR also secured placement for its breakthrough oral thin film strip, Nutri-Strips™ on the shelves of CVS and Nutri-Strip technology is proprietary to Sera Labs and is the result of years of research and over 25 patents by the CURR development team.

Nancy Duitch, CEO of Sera Labs and Chief Strategy Officer of CURR, said, “This is another fantastic achievement in branding and expansion. Our goal is to differentiate our products using advanced and proprietary technologies, including unique high-tech delivery systems. Our formulations are derived from scientifically proven ingredients and combine problem-solving attributes with beautiful packaging that stands out on the shelf. Additionally, our brand’s connection to one of the world’s most respected and recognized players: Nicole Kidman – who is a strategic partner and global brand ambassador – makes our company and our brand a fierce competitor in the beauty and wellness industry.

 CURR and Milagro Pharmaceuticals Collaborate for Registration and Approval for Sale of Sildenafil Oral Thin Film in Mexico

On March 3, CURR and Milagro Pharmaceuticals, which seek first-mover advantage in target health and wellness markets through key collaborations, announced their collaboration to register and sell in Mexico a number of CURR OTC and medical compounds that utilize CUREform™, CURR’s patented drug delivery system platform for oral thin films (OTFs).

OTF products that will be marketed and sold in Mexico through key distribution partners include:

• CUREfilm Blue™ – an oral soluble form of sildenafil citrate (the active ingredient found in Viagra®1) for the treatment of erectile dysfunction (ED).

• Vitamin D3 – which provides a convenient weekly dose of 40,000 IU of vitamin D

• An electrolyte energy boost – which provides a healthier, sugar-free alternative to energy drinks

• Sleep – a dose of melatonin that dissolves on the tongue so it can be taken even after you’ve gone to bed.

CURR plans to select a distribution partner for the LATAM territory in the coming months.

 Exclusive international agreement with the main Canadian distributor

On December 9, CURR announced its global expansion into Canada by engaging Northern Response International for the exclusive distribution of all of its clean, herbal Seratopic Revolution.® skincare line, which features stellar packaging, affordable pricing, an exclusive delivery system and global brand ambassador CURR and international icon Nicole Kidman.

Northern Response International is one of the leading distributors in Canada and will sell the CURR range through direct-to-consumer channels and major wholesalers/retailers in the Canadian market, positioning Seratopical Revolution as a mass range. Northern Response is known for building brands in Canada for some of the largest lines of health, wellness and beauty products in the United States, including: ProActiv®Sonicare® Toothbrush, meaningful beauty®and Beach Body to name a few.

 Patent approval for CUREfilm Blue™ technology

On November 16, CURR announced that it had received a Notice of Grant from the United States Patent Office (USPTO) stating that U.S. Patent No. 11,179,331 (the ‘331 patent) was scheduled to issue on November 23, 2021. The patent’ 331, entitled “Oral Soluble Film Containing Sildenafil Citrate”, covers the product CURR CUREfilm Blue™, an oral soluble film of sildenafil citrate (the active ingredient found in Viagra®1) for the treatment of erectile dysfunction (ED). CURR is seeking approval for this product through the 505(b)(2) regulatory pathway.

CUREfilm Blue™ uses CURR’s patented and proprietary fast-dissolving drug delivery platform, known as CUREfilm™, to deliver the active pharmaceutical ingredient (API) sildenafil citrate.

The global erectile dysfunction drugs market is expected to grow at a CAGR of 6% and reach approximately US$6.6 billion by 2025, with sildenafil accounting for the majority of the market, according to a report by QYR Research.

For more information about CURE Pharmaceutical, Inc. (OTCQB: CURR), visit: and

DISCLAIMER: Products listed are THC-free and/or Farm Bill 2018 compliant.
DISCLAIMER: This article is for informational purposes only and does not constitute a recommendation to buy or sell stocks.

6176823625 ext.
write to us here
Visit us on social media:

Nicole Kidman’s skincare routine: Reaction and thoughts from @Susan Yara | #SKIN CARE


About Author

Comments are closed.